Emma Akuffo, BSc, PhD, MBA
Director of Study Management

Emma oversees the Study Management, Advanced Research Science and Quality Assurance teams at Richmond Pharmacology.

During her 10 years at Richmond Pharmacology, Emma has worked on over 100 Early Phase Studies ensuring optimal delivery of clinical trial outcomes for our sponsors. This has been achieved through efficient, streamlined processes, the production of high quality documentation and stringent regulatory compliance.

Prior to working at Richmond Pharmacology, Emma worked on various drug development projects within the biotechnology and pharmaceutical industry as well as academia.

Emma is a full member of the British Pharmacological Society and holds a BSc in Biology & Chemistry, PhD in Biochemistry and an MBA.

Back to experts

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event